InvestorsHub Logo
Followers 229
Posts 21457
Boards Moderated 2
Alias Born 08/03/2006

Re: None

Thursday, 12/01/2022 9:40:12 AM

Thursday, December 01, 2022 9:40:12 AM

Post# of 853
SCYNEXIS Announces FDA Approval of Second Indication for BREXAFEMME® (ibrexafungerp tablets) for Reduction in Incidence of Recurrent Vulvovaginal Candidiasis


https://finance.yahoo.com/news/scynexis-announces-fda-approval-second-130000442.html


Thinking this puppy plays well into next summer.


Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?

"We hope not." Richard Dennis

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SCYX News